Last reviewed · How we verify

Surgeon-Initiated Local Anesthetic

University of Wisconsin, Madison · FDA-approved active Small molecule

Surgeon-Initiated Local Anesthetic is a Local anesthetic Small molecule drug developed by University of Wisconsin, Madison. It is currently FDA-approved for Intraoperative and postoperative pain management during surgical procedures.

Surgeon-initiated local anesthetic blocks nerve conduction at the site of surgical administration to provide localized pain relief during and after surgical procedures.

Surgeon-initiated local anesthetic blocks nerve conduction at the site of surgical administration to provide localized pain relief during and after surgical procedures. Used for Intraoperative and postoperative pain management during surgical procedures.

At a glance

Generic nameSurgeon-Initiated Local Anesthetic
SponsorUniversity of Wisconsin, Madison
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaSurgery/Anesthesia
PhaseFDA-approved

Mechanism of action

Local anesthetics work by inhibiting sodium channel influx in nerve cell membranes, preventing depolarization and transmission of pain signals. When administered directly by the surgeon at the operative site, they provide regional anesthesia without systemic effects, reducing the need for general anesthesia or systemic opioids during surgery.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Surgeon-Initiated Local Anesthetic

What is Surgeon-Initiated Local Anesthetic?

Surgeon-Initiated Local Anesthetic is a Local anesthetic drug developed by University of Wisconsin, Madison, indicated for Intraoperative and postoperative pain management during surgical procedures.

How does Surgeon-Initiated Local Anesthetic work?

Surgeon-initiated local anesthetic blocks nerve conduction at the site of surgical administration to provide localized pain relief during and after surgical procedures.

What is Surgeon-Initiated Local Anesthetic used for?

Surgeon-Initiated Local Anesthetic is indicated for Intraoperative and postoperative pain management during surgical procedures.

Who makes Surgeon-Initiated Local Anesthetic?

Surgeon-Initiated Local Anesthetic is developed and marketed by University of Wisconsin, Madison (see full University of Wisconsin, Madison pipeline at /company/university-of-wisconsin-madison).

What drug class is Surgeon-Initiated Local Anesthetic in?

Surgeon-Initiated Local Anesthetic belongs to the Local anesthetic class. See all Local anesthetic drugs at /class/local-anesthetic.

What development phase is Surgeon-Initiated Local Anesthetic in?

Surgeon-Initiated Local Anesthetic is FDA-approved (marketed).

What are the side effects of Surgeon-Initiated Local Anesthetic?

Common side effects of Surgeon-Initiated Local Anesthetic include Local tissue irritation or inflammation, Systemic toxicity (if absorbed in high concentrations), Allergic reaction (rare, depending on anesthetic agent).

What does Surgeon-Initiated Local Anesthetic target?

Surgeon-Initiated Local Anesthetic targets Voltage-gated sodium channels and is a Local anesthetic.

Related